Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) have received an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $86.8571.

A number of equities research analysts have recently issued reports on ESTA shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a research note on Monday, December 29th. Mizuho boosted their target price on Establishment Labs from $90.00 to $100.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Needham & Company LLC raised their price target on Establishment Labs from $84.00 to $86.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Wall Street Zen downgraded Establishment Labs from a “buy” rating to a “hold” rating in a report on Saturday. Finally, BTIG Research increased their target price on Establishment Labs from $86.00 to $88.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th.

Insider Transactions at Establishment Labs

In other Establishment Labs news, Director Quiros Juan Jose Chacon sold 3,575 shares of the business’s stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of $60.08, for a total transaction of $214,786.00. Following the sale, the director directly owned 1,220,004 shares in the company, valued at $73,297,840.32. This represents a 0.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.44% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Kestra Advisory Services LLC purchased a new stake in Establishment Labs during the 4th quarter worth approximately $47,000. Quarry LP acquired a new stake in Establishment Labs during the 3rd quarter worth approximately $34,000. State of Wyoming purchased a new position in Establishment Labs in the 3rd quarter valued at approximately $71,000. MV Capital Management Inc. purchased a new position in Establishment Labs in the 4th quarter valued at approximately $146,000. Finally, Osaic Holdings Inc. grew its stake in shares of Establishment Labs by 900.0% in the second quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after acquiring an additional 1,800 shares in the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Performance

NASDAQ ESTA opened at $55.31 on Monday. The stock has a market cap of $1.62 billion, a PE ratio of -31.79 and a beta of 0.91. The company has a current ratio of 3.04, a quick ratio of 2.00 and a debt-to-equity ratio of 10.51. Establishment Labs has a twelve month low of $26.56 and a twelve month high of $83.31. The stock has a fifty day simple moving average of $68.98 and a 200-day simple moving average of $62.21.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings data on Tuesday, February 24th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.13. Establishment Labs had a negative net margin of 24.19% and a negative return on equity of 201.79%. The firm had revenue of $64.62 million for the quarter, compared to analyst estimates of $63.80 million. During the same period in the previous year, the firm earned ($1.19) EPS. Establishment Labs’s revenue was up 45.2% on a year-over-year basis. Equities analysts anticipate that Establishment Labs will post -2.41 earnings per share for the current year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.